This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Innovation & Partnership Summit
March 21-23, 2023
Delivered as a Hybrid EventPhiladelphia Marriott Downtown

Panna Sharma
CEO, President at Lantern Pharma, Inc.


Panna Sharma is the President and Chief Executive Officer of Lantern Pharma Inc. (NASDAQ: LTRN). As CEO, he is responsible for developing Lantern’s strategic vision, working closely with venture investors to raise capital, and placing the company at the forefront of artificial intelligence (AI) and genomics in the development of its pipeline of precision oncology therapies. Prior to joining Lantern in 2018, Sharma was the President and CEO of Cancer Genetics and the Managing Partner and CEO of TSG Partners. He attended Boston University in the University Professors Program and focused his studies on Philosophy of Science, Neural Networks and AI.

Agenda Sessions

  • Using AI to Accelerate the Drug Discovery and Development Process for Rare Cancers